Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RARE
Recent news which mentions RARE
< Previous
1
2
3
4
Next >
Evaluating Ultragenyx Pharmaceutical: Insights From 7 Financial Analysts
November 06, 2024
Tickers
RARE
Tags
RARE
Analyst Ratings
Market News
From
Benzinga
A Look Ahead: Ultragenyx Pharmaceutical's Earnings Forecast
November 04, 2024
Tickers
RARE
Tags
Market News
RARE
Earnings
From
Benzinga
Decoding 10 Analyst Evaluations For Ultragenyx Pharmaceutical
October 21, 2024
Tickers
RARE
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
Breaking Down Ultragenyx Pharmaceutical: 10 Analysts Share Their Views
September 20, 2024
Tickers
RARE
Tags
Analyst Ratings
RARE
Market News
From
Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
Tickers
NEWS
NVS
RARE
TMO
Tags
Media
Market News
RARE
From
Benzinga
3 Genomics Stocks That May Transform Personalized Medicine
August 06, 2024
Tickers
RARE
SRPT
TECH
Tags
SRPT
NASDAQ:RARE,NASDAQ:SRPT,NASDAQ:TECH
Stocks to Buy
From
InvestorPlace
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
Tickers
ALNY
AZN
BIIB
IONS
Tags
RARE
Analyst Ratings
Market News
From
Benzinga
Unveiling 14 Analyst Insights On Ultragenyx Pharmaceutical
July 22, 2024
Tickers
RARE
Tags
Market News
RARE
Analyst Ratings
From
Benzinga
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Tickers
AMGN
BLUE
BMY
GILD
Tags
Stocks to Buy
RARE
NYSE:BMY,NASDAQ:NBIX,NASDAQ:AMGN,NASDAQ:GILD,NYSE:NVS,NASDAQ:BLUE,NASDAQ:RARE
From
InvestorPlace
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Tickers
ADBE
ATI
BAND
BE
Tags
THMO
OCUL
Movers
From
Benzinga
Dave & Buster's Posts Downbeat Results, Joins J.Jill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 13, 2024
Tickers
JACK
JILL
NEWS
PLAY
Tags
Premarket
Markets
Movers
From
Benzinga
This United Airlines Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
June 06, 2024
Tickers
LULU
NEWS
RARE
RBRK
Tags
RARE
Analyst Ratings
RBRK
From
Benzinga
Peeling Back The Layers: Exploring Ultragenyx Pharmaceutical Through Analyst Insights
May 31, 2024
Tickers
RARE
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells
May 22, 2024
Tickers
NEWS
RARE
TMO
Tags
Stories That Matter
Top Stories
General
From
Benzinga
RARE Stock Earnings: Ultragenyx Pharmaceutical Misses EPS, Misses Revenue for Q1 2024
May 02, 2024
Tickers
RARE
Tags
Market News
NASDAQ:RARE
RARE
From
InvestorPlace
Forecasting The Future: 11 Analyst Projections For Ultragenyx Pharmaceutical
April 22, 2024
Tickers
RARE
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
Tickers
LGVN
MRNS
NEWS
NMRA
Tags
News
Earnings
Commodities
From
Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Tickers
ADIL
AEYE
ATHE
BB
Tags
YSG
CMAX
NVX
From
Benzinga
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
April 15, 2024
Tickers
LGVN
MRNS
NEWS
NMRA
Tags
NMRA
Markets
Mid Day Market Update
From
Benzinga
Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study
April 15, 2024
Tickers
NEWS
RARE
Tags
General
Movers
Briefs
From
Benzinga
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
Tickers
COGT
MOH
MRNS
NEWS
Tags
Penny Stocks
Trading Ideas
Benzinga
From
Benzinga
Expert Outlook: Ultragenyx Pharmaceutical Through The Eyes Of 9 Analysts
April 05, 2024
Tickers
RARE
Tags
Market News
RARE
Analyst Ratings
From
Benzinga
Analyst Scoreboard: 8 Ratings For Ultragenyx Pharmaceutical
March 18, 2024
Tickers
RARE
Tags
Market News
Analyst Ratings
RARE
From
Benzinga
Recap: Ultragenyx Pharmaceutical Q4 Earnings
February 15, 2024
Tickers
RARE
Tags
BZI/Recaps
Market News
RARE
From
Benzinga
The Latest Analyst Ratings For Ultragenyx Pharmaceutical
February 15, 2024
Tickers
RARE
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
Tickers
AEM
AGIO
AL
ALKS
Tags
SAND
MYTE
RPRX
From
Benzinga
Preview: Ultragenyx Pharmaceutical's Earnings
February 14, 2024
Tickers
RARE
Tags
Benzinga
BZI/EP
Earnings
From
Benzinga
4 Analysts Have This To Say About Ultragenyx Pharmaceutical
January 19, 2024
Tickers
RARE
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
December 08, 2023
Tickers
RARE
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
Analyst Ratings for Ultragenyx Pharmaceutical
November 03, 2023
Tickers
RARE
Tags
Market News
RARE
Analyst Ratings
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.